Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias

Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease

(2021) Tatsuhiro Terada et al.   Molecular Neurodegeneration

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

(2020) Anne-Laure Mahul-Mellier et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glucose, glycolysis, and neurodegenerative diseases

(2020) Bor Luen Tang   JOURNAL OF CELLULAR PHYSIOLOGY

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

(2020) Nicolas R. Barthélemy et al.   NATURE MEDICINE

Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer’s Disease Carrying Apolipoprotein E4 Genotype

(2020) Caterina Motta et al.   JOURNAL OF ALZHEIMERS DISEASE

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

(2020) Stephen C. Cunnane et al.   NATURE REVIEWS DRUG DISCOVERY

The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer’s Disease

(2020) Sanjib Guha et al.   MOLECULAR NEUROBIOLOGY

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease

(2020) Nabil Itzi Luna-Viramontes et al.   Frontiers in Cellular Neuroscience

Pro - and anti-inflammatory cytokines in the CSF of Alzheimer´s disease patients and their correlation with cognitive decline

(2019) R. Taipa et al.   NEUROBIOLOGY OF AGING

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease

(2019) P. Hemachandra Reddy et al.   Cells

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

(2019) Yu Yamazaki et al.   Nature Reviews Neurology

Intersection of pathological tau and microglia at the synapse

(2019) Thomas Vogels et al.   Acta Neuropathologica Communications

Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases

(2019) Tomoya Kon et al.   NEUROPATHOLOGY

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer’s disease

(2018) Caterina Motta et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Lactate in the brain: from metabolic end-product to signalling molecule

(2018) Pierre J. Magistretti et al.   NATURE REVIEWS NEUROSCIENCE

α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton

(2018) Dalila G. Ordonez et al.   NEURON

α-Synuclein and Tau: Mitochondrial Kill Switches

(2018) Ulrike Pech et al.   NEURON

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease

(2018) Gina M. Broom et al.   NUTRITION

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

(2017) Tobias Skillbäck et al.   NEUROBIOLOGY OF AGING

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Oxidative stress in neurodegenerative disease: causation or association?

(2017) Jeremy M. Van Raamsdonk et al.   Oncotarget

Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease

(2016) Stephen C. Cunnane et al.   Annals of the New York Academy of Sciences

The amyloid hypothesis of Alzheimer's disease at 25 years

(2016) Dennis J Selkoe et al.   EMBO Molecular Medicine

A Mitocentric View of Alzheimer’s Disease

(2016) Hao Hu et al.   MOLECULAR NEUROBIOLOGY

There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases

(2016) Sebastien Paillusson et al.   TRENDS IN NEUROSCIENCES

Ion Channel Formation by Tau Protein: Implications for Alzheimer’s Disease and Tauopathies

(2015) Nirav Patel et al.   BIOCHEMISTRY

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease

(2014) C Liguori et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism

(2014) Ilie-Cosmin Stancu et al.   Molecular Neurodegeneration

Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice

(2012) Wilhelmina G. Leen et al.   PLoS One

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia

(2010) P.E. Spies et al.   Current Alzheimer Research

Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain

(2008) Latha Devi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ketone bodies as a therapeutic for Alzheimer’s disease

(2008) Samuel T. Henderson   Neurotherapeutics